Vanguard Group Inc. increased its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,514,736 shares of the company's stock after buying an additional 20,604 shares during the quarter. Vanguard Group Inc. owned about 3.74% of Phibro Animal Health worth $31,809,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in PAHC. Quantbot Technologies LP grew its position in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after purchasing an additional 2,018 shares during the period. New York State Teachers Retirement System grew its holdings in shares of Phibro Animal Health by 16.7% during the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after buying an additional 775 shares during the last quarter. Amundi increased its position in shares of Phibro Animal Health by 185.5% during the fourth quarter. Amundi now owns 9,855 shares of the company's stock worth $212,000 after acquiring an additional 6,403 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Phibro Animal Health by 7.4% in the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after acquiring an additional 906 shares during the last quarter. Finally, Ieq Capital LLC bought a new position in Phibro Animal Health in the 4th quarter valued at about $302,000. Institutional investors own 99.34% of the company's stock.
Analyst Ratings Changes
PAHC has been the subject of a number of recent research reports. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday, March 25th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $21.00.
Read Our Latest Analysis on Phibro Animal Health
Phibro Animal Health Stock Performance
NASDAQ PAHC traded down $1.10 during trading hours on Tuesday, reaching $16.81. 222,101 shares of the company were exchanged, compared to its average volume of 189,957. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The stock has a market capitalization of $680.97 million, a P/E ratio of 35.02, a P/E/G ratio of 0.45 and a beta of 0.63. Phibro Animal Health Co. has a 1 year low of $12.30 and a 1 year high of $26.55. The business's 50 day simple moving average is $22.11 and its 200-day simple moving average is $22.43.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities research analysts expect that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.
Phibro Animal Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.86%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
